Cardiovascular Risks of GLP-1 Medications GLP-1 receptor agonists, like semaglutide, liraglutide, dulaglutide, and tirzepatide, are widely used for managing type 2 diabetes and obesity
Purified phosphatidylcholine from soybean lecithin, caprylic/capric triglycerides, alcohol, glyceryl stearate oleic acid, ascorbyl palmitate, tocopherols, glycerine, orange flavor
But here's what your doctor might not have emphasised: research shows that up to 40% of the weight lost on these medications can come from lean muscle mass, not just fat
Cardiovascular outcome trials, once considered ancillary, can strategically reposition metabolic drugs as cardioprotective agents
Saxenda for weight management), prescribed under specific NICE guidance and MHRA regulation
Many clinics sell packages of 412 injections at discounted rates